Annual and transition report of foreign private issuers [Sections 13 or 15(d)]

DERIVATIVE WARRANTS LIABILITIES AND PREFUNDED WARRANTS

v3.26.1
DERIVATIVE WARRANTS LIABILITIES AND PREFUNDED WARRANTS
12 Months Ended
Dec. 31, 2025
Derivative Warrants Liabilities And Prefunded Warrants [Abstract]  
DERIVATIVE WARRANTS LIABILITIES AND PREFUNDED WARRANTS [Text Block]
NOTE 16 -
DERIVATIVE WARRANTS LIABILITIES AND PREFUNDED WARRANTS
 
  A.
From time to time the Company entered into a non-brokered private placement offering transactions or settlement agreements under which the Company issued units that consist of common shares and warrants which are exercisable into common shares over a limited period of the time at an exercise price which is denominated in foreign currency and/or as the warrants might be exercisable to variable number of shares due to cashless exercise mechanism. As a result of the above, such warrants are accounted for as a derivative warrants liability which is measured at fair value through profits and losses.
 
At the initial date and subsequently, the fair value of the warrants is estimated by management using the assistance of external appraiser based on Black and Scholes option pricing model, when unrealized gains or losses are included in finance income (expense), respectively, until expiration or exercise of the warrants.
 
The following table summarizes the observable inputs used in the valuation of the derivative warrants liabilities as of December 31, 2025 and 2024:
 
   
December 31, 2025
   
December 31, 2024
 
   
Series 2024 (*)
   
Series 2023
   
Series 2021
   
Series 2024
   
Series 2023
   
Series 2021
 
                                     
   Share price (in CAD)
   
1.91
     
1.91
     
1.91
     
3.25
     
3.25
     
3.25
 
   Exercise price (in CAD)
   
3.43
     
12.34
     
59.21
     
4.32
     
12.95
     
62.14
 
   Expected volatility (%)
   
67.72
%
   
67.28
%
   
67.3
%
   
72.2
%
   
75.7
%
   
75.7
%
   Risk-free interest rate (%)
   
2.90
%
   
3.63
%
   
3.63
%
   
2.93
%
   
4.21
%
   
4.21
%
   Dividend yield (%)
   
-
     
-
     
-
     
-
     
-
     
-
 
   Expected term (years)
   
4.59
     
0.37
     
0.37
     
1.88
     
1.35
     
1.35
 
                                                 
   Number of warrants
   
742,517
     
818,818
     
49,058
     
742,517
     
818,818
     
49,058
 
   Fair value per warrant (in CAD)
   
0.81
     
0.00
     
0.00
     
1.06
     
0.14
     
0.00
 
 
The following tabular presentation reflects the reconciliation of the total fair value of derivative warrants liabilities during the periods reported:
 
   
Series 2024
   
Series 2023
   
Series 2021
   
Total
 
                         
   Balances at January 1, 2023
 
$
-
   
$
-
   
$
8
   
$
8
 
   Issued (see Notes 18B1-18B2 below)
   
-
     
7,253
     
-
     
7,253
 
   Changes in fair value (**)
   
-
     
(7,215
)
   
(8
)
   
(7,223
)
   Balances at December 31, 2023
   
-
     
38
     
-
     
38
 
   Issued (see Note 18B3 below)
   
1,154
     
-
     
-
     
1,154
 
   Changes in fair value (**)
   
(367
)
   
62
     
-
     
(305
)
   Balances at December 31, 2024
   
787
     
100
     
-
     
887
 
   Changes in fair value (**)
   
(*) (186
)
   
(100
)
   
-
     
(286
)
   Balances at December 31, 2025
 
$
601
   
$
-
   
$
-
   
$
601
 
 
  (*)
Including, inter alia, the implication of execution of agreements dated August 13, 2025, with the holders of certain common share purchase warrants (the “Warrants”) originally issued as part of its private placement offering that closed on November 12, 2024 (the “2024 Private Placement”), pursuant to which the Company reduced the exercise price of each Warrant from $4.32 per common share to $3.43 per common share and extended the expiration date of each Warrant from November 12, 2026 to July 31, 2030.
 
  (**)
See Note 19F below.
 
  B.
For more information regarding prefunded warrants granted to Company's Chief Executive Officer, then Chairman of the Board and main shareholder, see also Note 18B4 below.